Mengchao Hepatobiliary Hospital

Running trials

• Recruiting

  Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection

  NCT06406816· Early phase 1· Yongyi Zeng· Source

• Recruiting

  Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

  NCT06349317· Phase 2· Yongyi Zeng· Source

• Recruiting

  A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

  NCT06280105· Phase 2· Meng Chao Hepatobiliary Hospital of Fujian Medical University· Source

• Recruiting

  A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

  NCT05409482· Meng Chao Hepatobiliary Hospital of Fujian Medical University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer4 recruiting

Conditions

Diseases this institution publishes on or runs trials for.

• Liver and biliary tract cancer94 works · 4 trials